The experience use of drug-coated & non drug-coated balloons in arteriovenous fistula at a six months period: brief report

In Vitro Determination of Drug Transfer from Drug-Coated Balloons

Drug-coated balloons are medical devices designed to locally deliver drug to diseased segments of the vessel wall. For these dosage forms, drug transfer to the vessel wall needs to be examined in detail, since drug released into the blood is cleared from the site. In order to examine drug transfer, a new in vitro setup was developed combining the estimation of drug loss during advancement to th...

Drug-coated balloons for the prevention of vascular restenosis.

From early in the history of percutaneous cardiovascular intervention, restenosis has been one of the most important clinical and biological measures of success, and a great deal of effort has been put into understanding the mechanisms responsible.1,2 Restenosis is the result of the interaction of a variety of mechanical and biological processes that begin immediately after balloon injury, incl...

Lutonix: Back To The Future With Drug-Coated Balloons

Long-Term Results of Drug-Coated Balloons for Drug-Eluting In-Stent Restenosis: Gaining Perspective.

SEE PAGE 877 C ompared with the use of bare-metal stents (BMS), the introduction of drug-eluting stents (DES) drastically reduced the occurrence of both clinical and angiographic in-stent restenosis (ISR) (1,2). Recent reports also suggest that new-generation DES could provide a safety edge by reducing the risk of stent thrombosis. The widespread use of DES enabled the expansion of coronary int...

Drug-coated balloons: a novel advance in the percutaneous treatment of coronary and peripheral artery disease

2015 Since the introduction of plain old balloon angioplasty, there have been several improvements in the treatment of coronary artery disease, with the advent of bare metal stents and drug-eluting stents being two notable milestones. Although these stents confer better acute gains in coronary interventions, the risk of instent restenosis (ISR) remains, especially with bare metal stents. Hence,...

Effect of Drug-Coated Balloons in Native Coronary Artery Disease Left With a Dissection.

OBJECTIVES The authors sought to understand the clinical and angiographic outcomes of dissections left after drug-coated balloon (DCB) angioplasty. BACKGROUND Second-generation DCB may be an alternative to stents in selected populations for the treatment of native coronary lesions. However, the use of these devices may be hampered by a certain risk of acute vessel recoil or residual coronary ...